Start New EnglishEspañol中文РусскийالعربيةTiếng ViệtFrançaisDeutsch한국어Tagalog Library Performance
BETA v.3.0

2025 ICD-10-CM code Z18.09

Presence of other retained radioactive fragments in the body.

A Z code should not be used as a primary diagnosis if the encounter is for treatment of an injury or illness.If a procedure is performed related to the retained fragment, a corresponding procedure code must accompany Z18.09.

The medical necessity for using Z18.09 rests on the presence of a foreign radioactive fragment retained within the body that impacts the patient's health status.This necessitates monitoring or intervention, justifying the use of the code.

Clinicians should document the type and location of the retained radioactive fragments, any associated symptoms, and any planned management or monitoring.

In simple words: This code indicates the presence of small pieces of radioactive material left inside the body, other than the specific types mentioned in other codes.

This code describes a situation where a patient has retained radioactive fragments, other than those specified elsewhere, within their body.This could include depleted isotope fragments or other non-therapeutic radioactive materials.This is a reportable condition influencing the patient's health status.

Example 1: A patient undergoing a nuclear medicine procedure has a small amount of radioactive tracer inadvertently leak into surrounding tissues. The leaked tracer, now considered a retained fragment, is documented with Z18.09., A worker in a nuclear power plant experiences a minor incident resulting in minute radioactive particles becoming embedded in their skin. After initial decontamination, some particles remain, necessitating the use of Z18.09., A patient receives radiotherapy with radioactive implants. After the intended treatment period, a fragment of the implant breaks off and remains within the body, requiring coding with Z18.09.

Documentation should clearly specify the type of radioactive fragment retained, the date and circumstances of the event leading to retention, the location of the fragment within the body, associated symptoms, and any planned treatment or monitoring.

** Z18.09 is exempt from the Present on Admission (POA) reporting requirement.

** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.

Discover what matters.

iFrame™ AI's knowledge is aligned with and limited to the materials uploaded by users and should not be interpreted as medical, legal, or any other form of advice by iFrame™.